Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E Tagliani

Showing results (1-10 of 7) with videos related to

Pageof 1
Sort By:
International Journal of Mycobacteriology|January 4, 2017
Reaching consensus on drug resistance conferring mutationsD M Cirillo, P Miotto, E Tagliani, et al.
The International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease|February 17, 2015
The impact of Xpert® MTB/RIF depends on service coordination: experience in Burkina FasoI Moyenga, A Roggi, G Sulis, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|April 14, 2019
Role and value of whole genome sequencing in studying tuberculosis transmissionV Nikolayevskyy, S Niemann, R Anthony, et al.
Microbiology Spectrum|December 8, 2022
Experiences from 4 Years of Organization of an External Quality Assessment for Mycobacterium tuberculosis Whole-Genome Sequencing in the European Union/European Economic AreaR M Anthony, E Tagliani, V Nikolayevskyy, et al.
The International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease|May 12, 2021
Therapeutic strategies and outcomes of MDR and pre-XDR-TB in Italy: a nationwide studyN Riccardi, L Saderi, E Borroni, et al.
Open Forum Infectious Diseases|August 21, 2024
Reflex Xpert MTB/XDR Testing of Residual Rifampicin-Resistant Specimens: A Clinical Laboratory-Based Diagnostic Accuracy and Feasibility Study in South AfricaC M Centner, R Munir, E Tagliani, et al.
BMC Infectious Diseases|January 19, 2024
Study protocol: a pragmatic, cluster-randomized controlled trial to evaluate the effect of implementation of the Truenat platform/MTB assays at primary health care clinics in Mozambique and Tanzania (TB-CAPT CORE)V N Leukes, J Hella, I Sabi, et al.
Pageof 1

Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
International Journal of Mycobacteriology|January 4, 2017
Reaching consensus on drug resistance conferring mutationsD M Cirillo, P Miotto, E Tagliani, et al.
The International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease|February 17, 2015
The impact of Xpert® MTB/RIF depends on service coordination: experience in Burkina FasoI Moyenga, A Roggi, G Sulis, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|April 14, 2019
Role and value of whole genome sequencing in studying tuberculosis transmissionV Nikolayevskyy, S Niemann, R Anthony, et al.
Microbiology Spectrum|December 8, 2022
Experiences from 4 Years of Organization of an External Quality Assessment for Mycobacterium tuberculosis Whole-Genome Sequencing in the European Union/European Economic AreaR M Anthony, E Tagliani, V Nikolayevskyy, et al.
The International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease|May 12, 2021
Therapeutic strategies and outcomes of MDR and pre-XDR-TB in Italy: a nationwide studyN Riccardi, L Saderi, E Borroni, et al.
Open Forum Infectious Diseases|August 21, 2024
Reflex Xpert MTB/XDR Testing of Residual Rifampicin-Resistant Specimens: A Clinical Laboratory-Based Diagnostic Accuracy and Feasibility Study in South AfricaC M Centner, R Munir, E Tagliani, et al.
BMC Infectious Diseases|January 19, 2024
Study protocol: a pragmatic, cluster-randomized controlled trial to evaluate the effect of implementation of the Truenat platform/MTB assays at primary health care clinics in Mozambique and Tanzania (TB-CAPT CORE)V N Leukes, J Hella, I Sabi, et al.
Pageof 1